Results of a phase II study examining brentuximab vedotin with chemotherapy for first line treatment of Hodgkin lymphoma.
Home / Resource Library / Brentuximab Vedotin, Doxorubicin, Vinblastine and Dacarbazine for Non-bulky Limited Stage Classical Hodgkin Lymphoma